Clinical Trial Update: Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety and tolerability of JBZ-001 in patients with advanced solid tumors and hematologic malignancies is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Tumor

Drugs mentioned

• JBZ-001

Snippet

Sponsor: Jabez Bioscience, Inc | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING